Deciphera Pharmaceuticals LLC

Company Profile

Deciphera Pharmaceuticals LLC had its IPO on 2017-09-28 under the ticker symbol DCPH.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Deciphera Pharmaceuticals LLC has a staff strength of 0 employees.

Stock update

Shares of Deciphera Pharmaceuticals LLC opened at $16.68 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $16.26 - $17.54, and closed at $16.64.

This is a -1.13% slip from the previous day's closing price.

A total volume of 504,445 shares were traded at the close of the day’s session.

In the last one week, shares of Deciphera Pharmaceuticals LLC have slipped by -2.12%.

Deciphera Pharmaceuticals LLC's Key Ratios

Deciphera Pharmaceuticals LLC has a market cap of $1.112 billion, indicating a price to book ratio of 2.853 and a price to sales ratio of 10.19.

In the last 12-months Deciphera Pharmaceuticals LLC’s revenue was $0.109 billion with a gross profit of $-0.142 billion and an EBITDA of $-0.229 billion. The EBITDA ratio measures Deciphera Pharmaceuticals LLC's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Deciphera Pharmaceuticals LLC’s operating margin was -213.1% while its return on assets stood at -27.8% with a return of equity of -60.6%.

In Q2, Deciphera Pharmaceuticals LLC’s quarterly earnings growth was a positive 0% while revenue growth was a positive 37.8%.

Deciphera Pharmaceuticals LLC’s PE and PEG Ratio

Forward PE

-

Trailing PE

-

PEG

None

Its diluted EPS in the last 12-months stands at $-4.898 per share while it has a forward price to earnings multiple of - and a PEG multiple of None. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Deciphera Pharmaceuticals LLC’s profitability.

Deciphera Pharmaceuticals LLC stock is trading at a EV to sales ratio of 7.35 and a EV to EBITDA ratio of -3.139. Its price to sales ratio in the trailing 12-months stood at 10.19.

Deciphera Pharmaceuticals LLC stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Deciphera Pharmaceuticals LLC ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Deciphera Pharmaceuticals LLC ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Deciphera Pharmaceuticals LLC’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Deciphera Pharmaceuticals LLC's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Deciphera Pharmaceuticals LLC paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$16.64

52-Week High

$20.88

52-Week Low

$6.51

Analyst Target Price

$17.9

Deciphera Pharmaceuticals LLC stock is currently trading at $16.64 per share. It touched a 52-week high of $20.88 and a 52-week low of $20.88. Analysts tracking the stock have a 12-month average target price of $17.9.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.